DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Niraula S, Gyawali B.
Optimal duration of adjuvant trastuzumab in treatment of early breast cancer: a meta-analysis of randomized controlled trials.
Breast Cancer Res Treat 2018;
DOI: 10.1007/s10549-018-4967-8.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.